Filtered By:
Condition: Hemorrhagic Stroke
Procedure: Cardiac Catheterization

This page shows you your search results in order of date.

Order by Relevance | Date

Total 25 results found since Jan 2013.

A Case of Giant Cell Arteritis Presenting As Catastrophic Posterior Circulation Stroke: A Diagnostic Dilemma
We describe a case of a 75-year-old woman who presented with jaw claudication and temporal headache. A colour duplex ultrasonography and later biopsy of the temporal arteries confirmed GCA and she was commenced on oral steroids. She was subsequently readmitted with a new worsening vision of both eyes and confusion. Her brain images revealed acute bilateral vertebral artery thrombus with haemorrhagic transformation. She was loaded on intravenous steroids. The next day she developed vomiting, bilateral visual loss and a cardiac arrest from ventricular fibrillation. Following the return of spontaneous circulation, she was tak...
Source: Atherosclerosis - August 17, 2022 Category: Cardiology Authors: Joshua Wong Siang Chan Ashit Shetty Source Type: research

Blunted cardiovascular effects of beta-blockers in patients with cirrhosis: Relation to severity?
ConclusionWe found the effect of beta-blockade on cardiac index in patients with advanced cirrhosis to be less potent than in patients with early cirrhosis, indicating that underlying cirrhotic cardiomyopathy increases, and the cardiac compensatory reserve becomes more compromised, with disease progression. The differential effects of beta-blockade in the left atrium may be used to predict the effect of beta-blockers on portal pressure, but further studies are needed to investigate this possibility.
Source: PLoS One - June 28, 2022 Category: Biomedical Science Authors: Puria Nabilou Source Type: research

Thrombolysis After Protamine Reversal of Heparin for Acute Ischemic Stroke After Cardiac Catheterization: Case Report and Literature Review
Conclusions: There are limited reports of protamine reversal of heparin before IV-tPA administration. To our knowledge, there are only 6 AIS cases including ours. Three cases received 0.6 mg/kg of tPA dose. All have favorable outcomes and no intracranial hemorrhage was reported. Protamine reversal of heparin for AIS after CC seems to be safe. Further studies are needed to confirm the therapeutic safety and efficacy of this strategy.
Source: The Neurologist - November 1, 2018 Category: Neurology Tags: Case Report/Case Series Source Type: research

"BEAST" at the University Of Virginia: Demographic and Phenotypic Data of Patients Contributing to a Biorepository to Establish the Etiology Of Sinovenous Thrombosis (P6.260)
Conclusions:Understanding the association between genetic determinants of CVST and phenotype has the potential to advance the diagnosis and management of this challenging entity. Enrollment in BEAST continues, with a replication cohort GWAS anticipated.Disclosure: Dr. Chiota-McCollum has nothing to disclose. Dr. Ehrlich has nothing to disclose. Dr. Johansen has received research support from the Graduate Medical Office at the University of Virginia for a quality improvement project investigating stroke in the setting of cardiac catheterization. . Dr. Rahman has nothing to disclose. Dr. Chapman has nothing to disclose. Dr. ...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Chiota-McCollum, N., Ehrlich, M., Johansen, M., Rahman, S., Chapman, S., Worrall, B. Tags: Non-Atherosclerotic Angiopathies and Cerebral Venous Thrombosis Source Type: research

Intermediate-term rates of stroke following cardiac procedures: the Nationwide Readmissions Database (P4.305)
Conclusions:Using a large, nationally representative database of inpatient admissions from 2013, we found that 90-day stroke rates are higher after cardiac procedures compared to non-cardiac procedures and non-surgical admissions. However, these rates are likely lower than previously reported.Disclosure: Dr. Stein has nothing to disclose. Dr. Thaler has nothing to disclose. Dr. Liang has nothing to disclose. Dr. Tuhrim has nothing to disclose. Dr. Dhamoon has nothing to disclose. Dr. Dhamoon has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Stein, L., Thaler, A., Liang, J., Tuhrim, S., Dhamoon, A., Dhamoon, M. Tags: Neuroepidemiology: Cerebrovascular Disease I Source Type: research

Acute neurologic complications of cardiac catheterization: clinical syndromes and outcomes (P6.296)
Conclusions:In this study, half of post-LHC neurologic syndromes prompting neurology consultation were cerebrovascular and half were non-cerebrovascular in nature. Hemiparesis was strongly associated with CVD, and positive visual phenomena were strongly associated with migraine aura.Disclosure: Dr. Horn has nothing to disclose. Dr. Selim has nothing to disclose. Dr. Leung has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Horn, S., Selim, M., Leung, L. Tags: Cardiovascular Issues in Ischemic Stroke Source Type: research

Recurrent contrast ‐induced encephalopathy following coronary angiography
Contrast‐induced encephalopathy (CIE) is an acute and reversible neurological disturbance associated with the intra‐arterial administration of iodinated contrast medium during cardiac catheterisation. It may manifest with encephalopathy, motor and sensory disturbances; vision disturbances, including cortical blindness, ophthalmoplegia, aphasia; and seizures. Disruption of the blood–brain barrier and direct neuronal toxicity are believed to be implicated in the pathophysiology of the syndrome. Symptoms appear soon after contrast administration and resolve completely within 24–48 h. Risk factors may include hypertens...
Source: Internal Medicine Journal - February 14, 2017 Category: Internal Medicine Authors: Roberto Spina, Neil Simon, Romesh Markus, David W. M. Muller, Krishna Kathir Tags: Brief Communication Source Type: research

Contrast ‐induced encephalopathy following cardiac catheterization
ConclusionsCIE is an important clinical entity to consider in the differential diagnosis of stroke following cardiac catheterization. Given that prognosis is excellent with supportive management only, physicians should be aware of it, and consider it prior to initiating thrombolysis. © 2016 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - November 28, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Roberto Spina, Neil Simon, Romesh Markus, David WM Muller, Krishna Kathir Tags: Coronary Artery Disease Source Type: research

Left atrial appendage closure: A single center experience and comparison of two contemporary devices
ConclusionsOur data show excellent safety and efficacy of LAA closure, irrespectively of the device utilized, in a population at high ischemic and hemorrhagic risk. The use of ACP and 3D‐TEE minimized the incidence of residual leaks; however, the clinical relevance of small peri‐device flow warrants further investigation. © 2016 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - August 26, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Filippo Figini, Patrizio Mazzone, Damiano Regazzoli, Giulia Porata, Neil Ruparelia, Francesco Giannini, Stefano Stella, Francesco Ancona, Eustachio Agricola, Nicoleta Sora, Alessandra Marzi, Andrea Aurelio, Nicola Trevisi, Paolo Della Bella, Antonio Colom Tags: Valvular and Structural Heart Diseases Source Type: research

Percutaneous left atrial appendage occlusion: Effect of device positioning on outcome
ConclusionsNo evidence for a difference in the occurrence of the safety and efficacy endpoint was found between patients with complete vs. incomplete ACP disc coverage of the LAA ostium. The risk of repositioning attempts in case of incomplete coverage does not seem to be warranted. Current findings need further confirmation in a larger scale clinical trial. © 2016 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - July 27, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Mathias Wolfrum, Adrian Attinger ‐Toller, Samera Shakir, Steffen Gloekler, Burkhardt Seifert, Aris Moschovitis, Ahmed Khattab, Francesco Maisano, Bernhard Meier, Fabian Nietlispach Tags: Valvular and Structural Heart Diseases Source Type: research

Risk of stroke in first-ever acute urinary retention: A 10-year population-based study
Conclusion There was significant difference in the risk of stroke between patients with and without AUR. Preventive measures should be taken for patients with AUR, which may be associated with an increased risk of subsequent stroke. Large-scale population-based studies in other countries and regions are recommended.
Source: Urological Science - July 1, 2016 Category: Urology & Nephrology Source Type: research

Asymptomatic migration of an AMPLATZER ™ Amulet™ left atrial appendage occluder through the mitral valve
An 84‐year‐old woman with a history of hemorrhagic stroke was admitted for a new cerebral ischemic event. While in hospital, she was diagnosed with paroxysmal atrial fibrillation. Owing to her high thromboembolic risk (CHA2DS2‐VASc score of 6) we performed left atrial appendage (LAA) closure using a 22‐mm AMPLATZER™ Amulet™. The procedure was successful. Systematic follow‐up with transthoracic echocardiography 8 hr later revealed that the LAA occluder had migrated and become entrapped in the mitral subvalvular apparatus. At this time, the patient was asymptomatic. The device was recovered percutaneously using...
Source: Catheterization and Cardiovascular Interventions - May 3, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Petru Mester, Antoine Dompnier, Lo ïc Belle Tags: Valvular and Structural Heart Diseases Source Type: research

Asymptomatic migration of an AMPLATZER™ Amulet™ left atrial appendage occluder through the mitral valve
An 84‐year‐old woman with a history of hemorrhagic stroke was admitted for a new cerebral ischemic event. While in hospital, she was diagnosed with paroxysmal atrial fibrillation. Owing to her high thromboembolic risk (CHA2DS2‐VASc score of 6) we performed left atrial appendage (LAA) closure using a 22‐mm AMPLATZER™ Amulet™. The procedure was successful. Systematic follow‐up with transthoracic echocardiography 8 hr later revealed that the LAA occluder had migrated and become entrapped in the mitral subvalvular apparatus. At this time, the patient was asymptomatic. The device was recovered percutaneously using...
Source: Catheterization and Cardiovascular Interventions - May 2, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Petru Mester, Antoine Dompnier, Loïc Belle Tags: Valvular and Structural Heart Diseases Source Type: research

Procedure- Related and Perioperative Strokes in Patients on Hemodialysis: A 10-Year Retrospective Study (P6.046)
Conclusion: Peri-procedural and peri-operative strokes are common in patients on Hemodialysis and highest risk is in the period soon after the procedure. Further studies should be directed towards better surgical risk stratification and stroke prevention pre-operatively in these patients.Disclosure: Dr. Sunbulli has nothing to disclose. Dr. Sachar has nothing to disclose. Dr. Rajamani has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Sunbulli, M., Sachar, P., Rajamani, K. Tags: In-Hospital Stroke and Stroke Complications Source Type: research

Incremental Value of the CRUSADE, ACUITY, and HAS-BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy Coronary Heart Disease
Conclusions Our analysis suggests that the CRUSADE score predicts major bleeding similarly to ACUITY and better than HAS BLED in an all-comer population with percutaneous coronary intervention and potentially identifies patients at higher risk of hemorrhagic complications when treated with a long-term dual antiplatelet therapy regimen. Clinical Trial Registration URL: http://clinicaltrials.gov. Unique identifier: NCT00611286.
Source: JAHA:Journal of the American Heart Association - December 7, 2015 Category: Cardiology Authors: Costa, F., Tijssen, J. G., Ariotti, S., Giatti, S., Moscarella, E., Guastaroba, P., De Palma, R., Ando, G., Oreto, G., Zijlstra, F., Valgimigli, M. Tags: Coronary Heart Disease Source Type: research